Allograft Failure After Alemtuzumab Induction in Renal Transplantation.

被引：0
|
作者：
Willicombe, M. [1 ]
Goodall, D. [1 ]
Charif, R. [1 ]
Galliford, J. [1 ]
McLean, A. [1 ]
Taube, D. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Kidney & Transplant Ctr, London, England
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01960
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C1803
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [21] Fungal and mycobacterial infections after Campath (alemtuzumab) induction for renal transplantation
    Walsh, R.
    Ortiz, J.
    Foster, P.
    Palma-Vargas, J.
    Rosenblatt, S.
    Wright, F.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (04) : 236 - 239
  • [22] Infectious complications after renal transplantation utilizing alemtuzumab induction.
    Walker, Jennifier K.
    Afaneh, Cheguevara I.
    Gallon, Lorenzo G.
    Kaufman, Dixon B.
    Stosor, Valentina
    Ison, Michael G.
    Leventhal, Joseph R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 503 - 504
  • [23] Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction
    Walker, Jennifer K.
    Scholz, Lisa M.
    Scheetz, Marc H.
    Gallon, Lorenzo G.
    Kaufman, Dixon B.
    Rachwalski, Erik J.
    Abecassis, Michael M.
    Leventhal, Joseph R.
    TRANSPLANTATION, 2007, 83 (07) : 874 - 882
  • [24] Low Incidence of NODAT with Alemtuzumab Induction and Tacrolimus Monotherapy without Steroids and MMF in Renal Transplantation.
    Chan, K.
    Lawrence, C.
    Charif, R.
    McLean, A.
    Cairns, T. D. H.
    Duncan, N.
    Goodall, D.
    Palmer, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 513 - 513
  • [25] Renal Allograft Outcome and Infectious Complications Following Antithymocyteglobulin and Alemtuzumab Used as Induction in Kidney Transplantation
    Jiamjariyaporn, T.
    Lumlertgul, D.
    Manoyos, A.
    Bunnachak, D.
    Opascharoensuk, V.
    Noppakhun, K.
    Suteeka, Y.
    TRANSPLANTATION, 2014, 98 : 643 - 644
  • [26] Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation.
    Choe, J.
    Au, J.
    Diamond, A.
    Ruggia-Check, C.
    Sehgal, S.
    Cordova, F.
    Shigemura, N.
    Keshavamurthy, S.
    Toyoda, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1011 - 1012
  • [27] Alemtuzumab Induction and Post-Transplant Glomerulonephritis in Kidney Transplantation.
    Koutroutsos, K.
    Willicombe, M.
    Charif, R.
    Roufosse, C.
    Loucaidou, M.
    Cook, T.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 534 - 535
  • [28] Surveillance Biopsy Findings with Alemtuzumab (ALZ) Induction in Kidney Transplantation.
    Madariaga, H.
    Ugarte, R.
    Drachenberg, C.
    Costa, N.
    Thomas, B.
    Bromberg, J.
    Weir, M.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 454 - 454
  • [29] Delayed allograft inflammation following alemtuzumab induction for kidney transplantation
    Heilman, Raymond L.
    Khamash, Hasan A.
    Smith, Maxwell L.
    Chakkera, Harini A.
    Moss, Adyr A.
    Reddy, Kunam S.
    CLINICAL TRANSPLANTATION, 2013, 27 (05) : 772 - 780
  • [30] Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab
    Kirk, AD
    Hale, DA
    Swanson, SJ
    Mannon, RB
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 1084 - 1085
12345